Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McCaffrey

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Determinants of hepatitis C translational initiation in vitro, in cultured cells and miceAnton P McCaffrey, Kazuo Ohashi, Leonard Meuse, et al.
Plos One|November 23, 2016
Small RNA Library Preparation Method for Next-Generation Sequencing Using Chemical Modifications to Prevent Adapter Dimer FormationSabrina Shore, Jordana M Henderson, Alexandre Lebedev, et al.
The New England Journal of Medicine|January 15, 1981
Histiocytosis-XM E Osband, J M Lipton, P Lavin, et al.
Analytical Chemistry|September 28, 2018
Efficient Production of On-Target Reads for Small RNA Sequencing of Single Cells Using Modified AdaptersRuba Khnouf, Sabrina Shore, Crystal M Han, et al.
Blood|July 1, 1981
Biochemical analysis of specific histamine HI and H2 receptors on lymphocytesM E Osband, E B Cohen, B R Miller, et al.
Hepatology (Baltimore, Md.)|November 25, 2010
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?Zhaowen Zhu, Anne T Wilson, Bruce A Luxon, et al.
Nature Biotechnology|May 13, 2003
Inhibition of hepatitis B virus in mice by RNA interferenceAnton P McCaffrey, Hiroyuki Nakai, Kusum Pandey, et al.
The New England Journal of Medicine|July 13, 1972
Effects of urea and cyanate on sickling in vitroG B Segel, S A Feig, W C Mentzer, et al.
Reviews of Infectious Diseases|July 1, 1990
Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once dailyT P Cooley, L M Kunches, C A Saunders, et al.
The New England Journal of Medicine|May 10, 1990
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trialT P Cooley, L M Kunches, C A Saunders, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Determinants of hepatitis C translational initiation in vitro, in cultured cells and miceAnton P McCaffrey, Kazuo Ohashi, Leonard Meuse, et al.
Plos One|November 23, 2016
Small RNA Library Preparation Method for Next-Generation Sequencing Using Chemical Modifications to Prevent Adapter Dimer FormationSabrina Shore, Jordana M Henderson, Alexandre Lebedev, et al.
The New England Journal of Medicine|January 15, 1981
Histiocytosis-XM E Osband, J M Lipton, P Lavin, et al.
Analytical Chemistry|September 28, 2018
Efficient Production of On-Target Reads for Small RNA Sequencing of Single Cells Using Modified AdaptersRuba Khnouf, Sabrina Shore, Crystal M Han, et al.
Blood|July 1, 1981
Biochemical analysis of specific histamine HI and H2 receptors on lymphocytesM E Osband, E B Cohen, B R Miller, et al.
Hepatology (Baltimore, Md.)|November 25, 2010
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?Zhaowen Zhu, Anne T Wilson, Bruce A Luxon, et al.
Nature Biotechnology|May 13, 2003
Inhibition of hepatitis B virus in mice by RNA interferenceAnton P McCaffrey, Hiroyuki Nakai, Kusum Pandey, et al.
The New England Journal of Medicine|July 13, 1972
Effects of urea and cyanate on sickling in vitroG B Segel, S A Feig, W C Mentzer, et al.
Reviews of Infectious Diseases|July 1, 1990
Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once dailyT P Cooley, L M Kunches, C A Saunders, et al.
The New England Journal of Medicine|May 10, 1990
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trialT P Cooley, L M Kunches, C A Saunders, et al.
Pageof 11